Cases & Deals

  • Home
  • Practices
  • Engage Bio develops global patent portfolio related to mRNA-encoded multi-specific binding molecules

Share

Engage Bio develops global patent portfolio related to mRNA-encoded multi-specific binding molecules

November 2022

Client(s) Engage Biologics, Inc.

Jones Day is representing Engage Biologics, Inc. in connection with the development of a global patent portfolio related to methods of treating disease using mRNAs that encode certain multi-specific binding molecules.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.